CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

RLAYRelay Therapeutics, Inc.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $18.05 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$3.96B
RECENT INSIDER TRADES
  • 2026-10-08 · Patel Sanjiv (President and CEO) · SELL
  • 2026-10-08 · Catinazzo Thomas (Chief Financial Officer) · SELL
  • 2026-09-09 · Patel Sanjiv (President and CEO) · SELL
  • 2026-09-09 · Bergstrom Donald A (President, R&D) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders278
Shares held275,040,912
Value$4.57B
Percent of shares outstanding125.51%
As of quarter end2026-06-30
RECENT NEWS
  • Relay Therapeutics CEO Sanjiv Patel sells $872,401 company stock
  • Relay Robotics Brings Autonomous Delivery to HCA Florida JFK Hospital
  • X-Chem Announces Phase 3 Milestone in Collaboration with Relay Therapeutics
  • Relay Therapeutics presents at Morgan Stanley Global Healthcare Conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Relay Therapeutics, Inc. (RLAY) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit